24M Technologies Secures Grant for Commercializing Energy Storage Technology

24M Technologies launched today as a new venture focused on commercializing next-generation energy storage systems based on technology out of A123 Systems, a developer and manufacturer of advanced Nanophosphate™ lithium ion batteries and systems, and Massachusetts Institute of Technology (MIT).

The company also announced that ARPA-E has awarded a total of $6M to a collaborative effort between 24M, MIT and Rutgers to further develop its technology, on top of previous funding to MIT from DARPA. 24M Technologies has secured $10M in Series A financing from Charles River Ventures and North Bridge Venture Partners to target high energy density applications at radically lower cost than previously attainable.

"We are thrilled to have the backing and validation of leaders in industry, finance, government and academia in the pursuit of game-changing energy storage solutions," said Throop Wilder, president of 24M. "The U.S. needs an all-hands-on-deck approach to compete in global markets that are heavily subsidized by foreign governments. Our team has a proven track record of innovation and commercial success in energy and technology fields. By harnessing this entrepreneurial skill set, we will develop safe, reliable, scalable and ultra-low cost energy storage systems."

24M will commercialize a novel technology that originated with A123 and was further developed at MIT. This technological advance combines attributes of rechargeable batteries, fuel cells, and flow batteries to enable scalable cost-effective, high-energy storage systems for emerging markets, including transportation and the electric grid. While A123 will have an equity stake in 24M and a seat on the company's board of directors, 24M remains a separate entity. A123 expects to work closely with 24M to support its development and commercialization efforts, while continuing to focus on delivering its core solutions to customers and maintaining its culture of innovation.

"This agreement with 24M highlights A123 Systems' substantial R&D pipeline and exemplifies our ongoing commitment to cultivating disruptive, innovative technologies while remaining focused on growing our grid and transportation businesses," said David Vieau, president and CEO of A123 Systems. "We believe that 24M's technology has the potential to reduce energy storage costs for transportation and grid applications, and we look forward to helping the company as it leverages our research innovations for the development of commercially viable systems."

24M is backed by two leading venture capital firms, Charles River Ventures and North Bridge Venture Partners that are providing $10 million in Series A financing. Both firms have selectively invested in energy companies over the last ten years with successful outcomes. "This is a very exciting project with huge potential to disrupt the existing energy storage market. We are thrilled to support 24M Technologies in this great endeavor," said Izhar Armony, general partner at Charles River.

"This is a unique founding team pursuing a disruptive technology," said Jeffrey McCarthy, general partner at North Bridge. "Dr. Yet-Ming Chiang, the lead inventor of the technology, is a renowned scientist and energy entrepreneur whom we have backed before. Yet, of course, continues to remain fully engaged with A123 in his capacity as a co-founder. Teaming with Throop Wilder, another proven entrepreneur with multiple technical and business successes whom we have also backed before, and Dr. W. Craig Carter, a world-renowned materials scientist, they have created exactly the kind of team required for winning outcomes."

24M has simultaneously received an award from the Department of Energy under the ARPA-E program to develop its revolutionary technology. Working in conjunction with MIT and Rutgers, who also received DARPA funding at an earlier stage of the project, the company will focus its efforts on commercializing its breakthrough technology.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.